Synergy Pharmaceuticals, Inc.
Commercial Physical And Biological Research NY, United States
| Nasdaq: SGYPW | Nasdaq: SGYPU | Nasdaq: SGYP
Similar to: Medivir AB, Advanced Cell Technology, Inc., Exelixis, Inc.
Synergy Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development of drugs to treat gastrointestinal disorders and diseases. Its proprietary drug candidate Plecanatide is a synthetic analog of the human gastrointestinal hormone uroguanylin, and functions by activating the Guanylate Cyclase C receptor on epithelial cells of the GI tract. The company was founded on November 15, 2005 and is headquartered in New York, NY.